Assetmark Inc. Sells 6,734 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)

Assetmark Inc. trimmed its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 10.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 56,577 shares of the biotechnology company’s stock after selling 6,734 shares during the quarter. Assetmark Inc. owned…